Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 18 (MTND6P18) is a pseudogene related to the mitochondrial NADH dehydrogenase 6 (MT-ND6) gene. Unlike the functional MT-ND6 gene, which encodes a subunit of the mitochondrial respiratory chain complex I and is relevant to mitochondrial function and some inherited diseases such as Leber hereditary optic neuropathy and Leigh syndrome[1][2][3][4], the pseudogene MTND6P18 does not code for a functional protein and has no documented role in biological pathways, disease, or pharmacology. As such, it is not considered a receptor, enzyme, transporter, or druggable therapeutic target. Its inclusion in target databases may be due to automated annotation or misclassification, not based on experimental evidence or clinical relevance. Note: If you intended to ask about the functional gene MT-ND6 rather than the pseudogene, please clarify, as the information for the protein-coding gene is vastly different and clinically significant[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 18 (MTND6P18).